TROVAFLOXACIN COMPARED WITH LEVOFLOXACIN, OFLOXACIN, CIPROFLOXACIN, AZITHROMYCIN AND CLARITHROMYCIN AGAINST UNUSUAL AEROBIC AND ANAEROBIC HUMAN AND ANIMAL BITE-WOUND PATHOGENS
Ejc. Goldstein et al., TROVAFLOXACIN COMPARED WITH LEVOFLOXACIN, OFLOXACIN, CIPROFLOXACIN, AZITHROMYCIN AND CLARITHROMYCIN AGAINST UNUSUAL AEROBIC AND ANAEROBIC HUMAN AND ANIMAL BITE-WOUND PATHOGENS, Journal of antimicrobial chemotherapy, 41(3), 1998, pp. 391-396
The activity of trovafloxacin and five other oral agents against 250 a
erobic and 137 anaerobic strains isolated from human and animal bite w
ounds was determined by an agar dilution method. Trovafloxacin was act
ive against all aerobic and fastidious facultative isolates at less th
an or equal to 0.5 mg/L and all anaerobes at less than or equal to 2 m
g/L (Bacteroides tectum, Porphyromonas salivosa and Prevotella heparin
olytica, less than or equal to 0.25 mg/L; Porphyromonas spp., less tha
n or equal to 0.5 mg/L; Prevotella spp. and peptostreptococci, less th
an or equal to 2.0 mg/L), except Fusobacterium nucleatum and other fus
obacteria (MIC90 less than or equal to 4 mg/L). Levofloxacin was gener
ally one to two dilutions more active than ofloxacin, while ciprofloxa
cin was active against aerobes (MIC less than or equal to 1 mg/L) but
less active against anaerobic strains (MIC90 less than or equal to 16
mg/L).